Drug Metabolism Letters

Editor-in-Chief:

Zhiyang Zhao
Alliance Pharma
Malvern, PA
USA

Back

Become EABM
Become Reviewer

Meet Our Co-Editor promotion: free to download

Volume:10   Issue:1
Pp: 1-1
Suresh K. Balani
DOI: 10.2174/187231281001160212152333



PREFACE free to download

Volume:10   Issue:1
Pp: 2-2
Suresh K. Balani
DOI: 10.2174/187231281001160212152632

Metabolism, Excretion and Pharmacokinetics of MLN3897, a CCR1 Antagonist, in Humans

Volume:10   Issue:1
Pp: 22-37
Sandeepraj Pusalkar, Mihaela Plesescu, Mark Milton, Suresh K. Balani, Swapan Chowdhury and Shimoga Prakash
DOI: 10.2174/1872312809666150602152423

Clinical Confirmation that the Selective JAK1 Inhibitor Filgotinib (GLPG0634) has a Low Liability for Drug-drug Interactions

Volume:10   Issue:1
Pp: 38-48
Florence Namour*, Julie Desrivot, Annegret Van der Aa, Pille Harrison, Chantal Tasset and Gerben van`t Klooster
DOI: 10.2174/1872312810666151223103353

Induction of Haemolysis and DNA Fragmentation in a Normal and Malarial-Infected Blood by Commonly - used Antimalarial Drugs in the North-Western Region of Nigeria

Volume:10   Issue:1
Pp: 49-55
Aliyu Muhammad, Mohammed Auwal Ibrahim, Ochuko Lucky Erukainure, Nathan Habila, Aimola Asegame Idowu, Uche Samuel Ndidi, Ibrahim Malami, Halliru Zailani, Zeenat Bello Kudan and Bilal Abdullahi Muhammad
DOI: 10.2174/187231281001160212150630

Common and Distinct Interactions of Chemical Inhibitors with Cytochrome P450 CYP1A2, CYP2A6 and CYP2B6 Enzymes

Volume:10   Issue:1
Pp: 56-64
Hannu Raunio, Risto O. Juvonen, Antti Poso, Maija Lahtela-Kakkonen and Minna Rahnasto-Rilla
DOI: 10.2174/1872312810666151204002456